Gigantism sufferers to benefit from new drug subsidy

17 Aug 2016


Australians who suffer from a rare disease that causes gigantism will benefit from a government subsidy that will give them cheap access to the drug pasireotide.

Sydney Morning Herald


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story